Search results
Results from the WOW.Com Content Network
Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. [ 6 ] [ 7 ] [ 10 ] It is also used to treat adults with heart failure and chronic kidney disease .
Dapagliflozin, (brand name Forxiga), was approved by the EU in 2012, the first SGLT2 inhibitor approved anywhere. [28] It was approved for use in the United States under the brand name Farxiga in January 2014. [29] Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. [30]
CaringBridge allows patients, caregivers, families, and friends to exchange information about a patient's medical condition on an ongoing basis. [3] The websites are designed to become conduits between patients, their families, friends, neighbors, and colleagues. [4]
Through this free service, specialists and master's-level clinicians offer confidential support and information to people living with dementia, caregivers, families and the public. [4] The Association also has free online tools to help people find answers, local resources and support.
Design, Dignity, Dementia: dementia-related design and the built environment Collates the progress which has been made in dementia-related design to date, including best practice from pioneers and innovators across multiple environments including in home/domestic settings, day and residential care, hospitals and public buildings and spaces. [38]
Regarding incidence, cohort longitudinal studies (studies where a disease-free population is followed over the years) provide rates between 10 and 15 per thousand person-years for all dementias and 5–8 for AD, [236] [237] which means that half of new dementia cases each year are Alzheimer's disease. Advancing age is a primary risk factor for ...
The idea of a collaboration between public institutions and private pharmaceutical companies to fund a large biomarker project to study AD and to speed up progress toward effective treatments for the disease was conceived at the beginning of the millennium by Neil S. Buckholz at the National Institute on Aging (NIA) and Dr. William Potter, at Eli Lilly and Company. [1]
Patient.info is an online resource providing information on health, lifestyle, disease and other medical related topics. The website's aim is to provide members of the public with up-to-date information on health related topics in the form of comprehensive leaflets (which can be read online or printed), blogs, wellbeing advice and videos.